Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,397 across all filing types
Latest filing 2010-08-31 Declaration of Voting R…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Fresenius SE: Release according to Article 26a, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (1260 characters) and explicitly states it is a 'Release according to Article 26a, Section 1 of the WpHG' concerning the 'Total Voting Rights Announcement' as of August 31, 2010. This is a mandatory regulatory disclosure regarding the total number of shares with voting rights. While it contains specific regulatory information, it is a brief announcement of a single data point (Total Voting Rights = 80,958,387) rather than a comprehensive report like a 10-K or IR. It does not fit perfectly into the defined categories like DVA (which is for *results* of a vote) or DIRS (insider trades). Given its nature as a mandatory, specific regulatory disclosure that doesn't fit the other specific codes (like DIV, SHA, etc.), the most appropriate fallback category is Regulatory Filings (RNS), as it is a general regulatory announcement distributed via DGAP.
2010-08-31 English
Analyst Conference Call - H1/10 Results
Call Transcript Classification · 98% confidence The document text explicitly states "# Analyst Conference Call – H1/10 Results" and includes a date (August 3, 2010), a Safe Harbor Statement, and detailed financial results broken down by segment and period (H1/10). The structure, content (financial tables, segment updates, outlook), and the title strongly indicate this is the transcript or presentation material from an earnings-related conference call. Comparing this to the definitions: - 10-K (Annual Report) or IR (Interim Report) are comprehensive reports, not typically titled as 'Analyst Conference Call'. - ER (Earnings Release) is usually a brief press release of highlights, whereas this document contains detailed segment breakdowns and tables. - CT (Call Transcript) is defined as the full text transcript of company conference calls (like earnings calls with Q&A). This document appears to be the presentation slides/script used during such a call. - IP (Investor Presentation) is a detailed presentation for investors. This fits the format well, but since it is specifically tied to the H1/10 results announcement, it is often distributed alongside or as part of the earnings call materials. Given the title "Analyst Conference Call" and the detailed financial data presented in a slide-like format, the most appropriate classification is Call Transcript (CT), as it represents the content delivered during that call, or Investor Presentation (IP). Since it is structured like a presentation with segment updates and financial tables, IP is a strong candidate, but CT covers the context of the 'Conference Call' itself. In many databases, the presentation deck accompanying an earnings call is classified as an Investor Presentation (IP). However, the presence of the 'Analyst Conference Call' header makes CT highly relevant. Given the detailed financial content, IP is often used for the deck itself. Let's re-evaluate based on the context of earnings. This is the material *for* the call discussing the H1 results. I will select IP as it represents the presentation material itself, which is a common format for these documents, even if delivered during a call. Revisiting the definitions: CT is the *full text transcript*. This looks like the *presentation slides*. Therefore, Investor Presentation (IP) is the best fit for the presentation material itself.
2010-08-26 English
DGAP-DD: Fresenius SE english
Director's Dealing Classification · 100% confidence The document explicitly contains the header "Directors’ Dealings" and details a transaction made by a person performing managerial responsibilities ("Rainer Baule, Member of a managing body"). The content describes the exercise of stock options and the sale of shares, which falls directly under the definition of insider trading or director transactions. This corresponds precisely to the 'Director's Dealing' category.
2010-08-10 English
DGAP-DD: Fresenius SE english
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "Directors’ Dealings" and details transactions made by a person in a managing body (Rainer Baule) regarding the company's ordinary shares, including the type of transaction (Exercise of stock options) and date. This directly corresponds to the definition of Director's Dealing reports.
2010-08-10 English
Q2 Report 2010
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Financial Report' for the Fresenius Group covering the 1st Half and 2nd Quarter of 2010. It contains comprehensive financial statements (income, cash flow, balance sheet), segment reporting, and management discussion and analysis. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report. H2 2010
2010-08-09 English
6-Monatsbericht 2010
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quartalsfinanzbericht' (Quarterly Financial Report) for Fresenius for the first half and second quarter of 2010. It contains comprehensive financial statements (income statement, balance sheet, cash flow), segment reporting, and management discussion and analysis (Konzern-Lagebericht). It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2010
2010-08-06 German

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.